Metropolitan Life Insurance Co. has been let out of a federal lawsuit alleging that an AstraZeneca employee's application for long-term disability was denied in violation of ERISA regulations. The pharmaceutical company, however, is still on the hook for some of the employee's other claims, including race and gender discrimination.
Deborah Brangman, who worked in AstraZeneca's marketing department from 1996 to 2011, filed the suit in early 2012 after she had been denied an extension of her short-term disability benefits by the company. She then sought long-term benefits from MetLife for her depression and anxiety. Her application was denied, as was her administrative appeal.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
